These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 29774872)
1. A signature based on survival-related genes identifies high-risk glioblastomas harboring immunosuppressive and aggressive ECM characteristics. Chen D; Chen D; Cao D; Hu J; Yao Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):368-382. PubMed ID: 29774872 [TBL] [Abstract][Full Text] [Related]
2. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas. Liu J; Li G Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726 [TBL] [Abstract][Full Text] [Related]
4. A robust two-gene signature for glioblastoma survival prediction. Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679 [TBL] [Abstract][Full Text] [Related]
6. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype. Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134 [TBL] [Abstract][Full Text] [Related]
7. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434 [TBL] [Abstract][Full Text] [Related]
8. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911 [TBL] [Abstract][Full Text] [Related]
9. Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme. Bao ZS; Zhang CB; Wang HJ; Yan W; Liu YW; Li MY; Zhang W CNS Neurosci Ther; 2013 Sep; 19(9):714-20. PubMed ID: 23663361 [TBL] [Abstract][Full Text] [Related]
10. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma. Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312 [TBL] [Abstract][Full Text] [Related]
12. A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme. Zhao J; Wang L; Hu G; Wei B Biomed Res Int; 2019; 2019():1649423. PubMed ID: 31531345 [TBL] [Abstract][Full Text] [Related]
13. A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma. Wang W; Zhang L; Wang Z; Yang F; Wang H; Liang T; Wu F; Lan Q; Wang J; Zhao J Oncotarget; 2016 Oct; 7(43):69991-69999. PubMed ID: 27588397 [TBL] [Abstract][Full Text] [Related]
14. Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas. Wang J; Ma J J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):240-249. PubMed ID: 30934097 [TBL] [Abstract][Full Text] [Related]
15. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844 [TBL] [Abstract][Full Text] [Related]
16. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Zhang C; Li J; Wang H; Song SW Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332 [TBL] [Abstract][Full Text] [Related]
17. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Jia D; Li S; Li D; Xue H; Yang D; Liu Y Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997 [TBL] [Abstract][Full Text] [Related]
18. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance. Cai J; Zhang W; Yang P; Wang Y; Li M; Zhang C; Wang Z; Hu H; Liu Y; Li Q; Wen J; Sun B; Wang X; Jiang T; Jiang C PLoS One; 2015; 10(5):e0126022. PubMed ID: 25978454 [TBL] [Abstract][Full Text] [Related]
19. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis. Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873 [TBL] [Abstract][Full Text] [Related]
20. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma. Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]